UNEX-42
UNX-BP-101
Phase 1 mab terminated
Quick answer
UNEX-42 for Bronchopulmonary Dysplasia is a Phase 1 program (mab) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Bronchopulmonary Dysplasia
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated